Colostrum
PreclinicalBiologic
Colostrum is one of 7 biologic programs targeting Neonatal. It is currently in Preclinical.
1
Indications
6
Total Trials
0
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
9 competitors in Neonatal
#DrugCompanyPhaseTrials
1Fabhalta
Johnson & JohnsonPhase 3
Rayos
RRoxane Laboratories
Phase 3
Ivig
ArgenxPhase 3
Immunoglobulins
CSL BehringPhase 3
Pitressin
AAultman Health Foundation
Phase 1
Pulmicort
SSalix
Phase 1
Colostrum
HHadassah Medical Organization
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Type 2 Diabetes1 trial
The Value of Using Colostrum Supplements on the Physical Performance and Cognitive Function in Healthy Subjects and Type 2 Diabetes
Completed·—·Phase 2·NCT06549556·100 enrolled
Neonatal1 trial
SARS CoV 2 Infection1 trial
Immune System1 trial
Oral Colostrum and Its Effect on Immune System
Unknown status·IInstituto Nacional de Perinatologia Isidro Espinosa de los Reyes·Phase 3·NCT03578341·96 enrolled
Cognitive Function1 trial
Colostrum Supplements Effect on the Physical Performance and Cognitive Function
Completed·—·Phase 2·NCT06007430·80 enrolled
1 more indication
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Colostrum. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- HHadassah Medical Organization